Clinical Trial Details
Braintumor Website

[Information provided by:, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03597165 : Incidental Genomics
AgesMin: 18 Years Max: N/A
Inclusion Criteria:

- Affected with Cancer

- Received a negative/inconclusive germline single gene test result for a cancer gene
mutation (e.g., BRCA1/2, MLH, MSH, PMS, etc.) in the past two years

- Or received a negative/inconclusive germline panel test result

- 18 years old or older

- Speak and read English

Exclusion Criteria:

- Are in advanced stage cancer (stage 4 /metastatic cancer)

- Currently in active treatment (chemotherapy, radiation, scheduled surgery) - patients
who are on Prophylactic Hormonal Therapy (eg tamoxifen) will be included

- Received a positive genetic test for a cancer gene mutation (e.g., BRCA1/2, MLH, MSH,
PMS, APC, MUTYH, etc.)

- Have not had single gene germline testing related to their primary cancer condition
(e.g., BRCA1/2 for breast/ovarian cancer, MLH, MSH, PMS colorectal cancer, etc.)

- Previously received genomic sequencing for any reason

- Currently pregnant or planning on getting pregnant (Including men whose partner is
pregnant or planning). Participants who become pregnant over the course of the study
will not be excluded.

- Do not speak or read English

- Under 18 years of age

- Have a family member participating in the study

- Participant in previous study of decision aid (Decision Aid RCT Study or Usability
LinksPermanent Link to THIS page:      |      Link to official listing

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557